Pediatrix Medical Group, Inc. $MD Shares Sold by Brandes Investment Partners LP

Brandes Investment Partners LP decreased its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 29.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 442,273 shares of the company’s stock after selling 188,438 shares during the period. Brandes Investment Partners LP’s holdings in Pediatrix Medical Group were worth $9,460,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Royal Bank of Canada boosted its position in shares of Pediatrix Medical Group by 23.8% during the 1st quarter. Royal Bank of Canada now owns 22,097 shares of the company’s stock valued at $320,000 after purchasing an additional 4,247 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Pediatrix Medical Group by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 51,253 shares of the company’s stock valued at $743,000 after purchasing an additional 2,251 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Pediatrix Medical Group by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 268,506 shares of the company’s stock valued at $3,891,000 after purchasing an additional 12,171 shares in the last quarter. Cetera Investment Advisers bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $145,000. Finally, Quantbot Technologies LP bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $99,000. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

NYSE MD opened at $23.62 on Thursday. The company has a 50 day simple moving average of $22.30 and a 200-day simple moving average of $21.70. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of 11.47 and a beta of 0.69. Pediatrix Medical Group, Inc. has a 52-week low of $11.84 and a 52-week high of $24.99.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $476.20 million during the quarter, compared to analyst estimates of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The firm’s revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.33 earnings per share. Equities research analysts predict that Pediatrix Medical Group, Inc. will post 2.09 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Truist Financial raised their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Monday, April 13th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th. Deutsche Bank Aktiengesellschaft set a $19.00 target price on shares of Pediatrix Medical Group in a report on Friday, February 20th. Finally, UBS Group raised their target price on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Pediatrix Medical Group has an average rating of “Hold” and a consensus price target of $22.50.

Insider Activity

In other news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.80% of the stock is owned by company insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.